Market Cap 89.57M
Revenue (ttm) 0.00
Net Income (ttm) -26.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 211,355
Avg Vol 883,650
Day's Range N/A - N/A
Shares Out 83.71M
Stochastic %K 50%
Beta 1.03
Analysts Strong Sell
Price Target $9.50

Company Profile

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutan...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 289 910 0850
Fax: 905 481 2394
Address:
2265 Upper Middle Road East, Suite 602, Oakville, Canada
NancyPelosi____insider
NancyPelosi____insider Sep. 16 at 9:13 PM
$CRDL esley please piss away more of my money!
1 · Reply
Rbyild
Rbyild Sep. 16 at 5:35 PM
$CRDL Dr. Garnett is the reason I decided to jump back in. With all his past success, connections and experience in the pharmaceutical industry he must have seen something promising…but so far he has basically brought nothing, other than an additional expense to the company. And the lack of any form 4’s from he and others at this stage is very concerning. I have actually sold as many as 50,000 shares in the last week or so. Quickly running out of cash, the risk of dilution and having to do a reverse split is becoming too big of risk, imo. GLTA
1 · Reply
Rome777
Rome777 Sep. 16 at 1:18 PM
$CRDL https://mailchi.mp/a5ec3dda4668/how-to-invest-in-a-company-that-is-taking-cash-out-of-the-equation-while-creating-diversified-revenues-6481173?e=e2de7eafa2
1 · Reply
Iceberg99
Iceberg99 Sep. 16 at 12:27 AM
0 · Reply
PDM21
PDM21 Sep. 15 at 2:23 PM
$CRDL I really thought that the fact that the last round of dilution/financing was relatively small was an indication that they had interested parties in talks about partnerships but I also expected more ownership from insiders between then and that kind of catalyst. The window of opportunity has been available. Not saying that still can’t happen but why does Tim Garnett still not hold a position? Can’t wait to see his salary compared to his position if they further dilute here.
1 · Reply
Pipelinepivots
Pipelinepivots Sep. 14 at 4:45 AM
MITQ is giving early MCVT energy. No hype. No dilution. Golden cross lining up. Once volume hits this float it could rip 100–200% in a blink. Most won’t catch it in time…. $CRDL $CVKD $NAOV $AMST $DRMA
0 · Reply
JOEtv
JOEtv Sep. 13 at 8:08 AM
$CRDL Never forget about me ;-)
0 · Reply
Myman2
Myman2 Sep. 12 at 1:51 PM
$CRDL Competitor knsa has tripled since i have been sitting in this Pretty annoying!
0 · Reply
ElieoG
ElieoG Sep. 12 at 12:44 AM
0 · Reply
Iceberg99
Iceberg99 Sep. 11 at 6:08 PM
0 · Reply
Latest News on CRDL
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Nov 13, 2024, 8:00 AM EST - 11 months ago

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index


NancyPelosi____insider
NancyPelosi____insider Sep. 16 at 9:13 PM
$CRDL esley please piss away more of my money!
1 · Reply
Rbyild
Rbyild Sep. 16 at 5:35 PM
$CRDL Dr. Garnett is the reason I decided to jump back in. With all his past success, connections and experience in the pharmaceutical industry he must have seen something promising…but so far he has basically brought nothing, other than an additional expense to the company. And the lack of any form 4’s from he and others at this stage is very concerning. I have actually sold as many as 50,000 shares in the last week or so. Quickly running out of cash, the risk of dilution and having to do a reverse split is becoming too big of risk, imo. GLTA
1 · Reply
Rome777
Rome777 Sep. 16 at 1:18 PM
$CRDL https://mailchi.mp/a5ec3dda4668/how-to-invest-in-a-company-that-is-taking-cash-out-of-the-equation-while-creating-diversified-revenues-6481173?e=e2de7eafa2
1 · Reply
Iceberg99
Iceberg99 Sep. 16 at 12:27 AM
0 · Reply
PDM21
PDM21 Sep. 15 at 2:23 PM
$CRDL I really thought that the fact that the last round of dilution/financing was relatively small was an indication that they had interested parties in talks about partnerships but I also expected more ownership from insiders between then and that kind of catalyst. The window of opportunity has been available. Not saying that still can’t happen but why does Tim Garnett still not hold a position? Can’t wait to see his salary compared to his position if they further dilute here.
1 · Reply
Pipelinepivots
Pipelinepivots Sep. 14 at 4:45 AM
MITQ is giving early MCVT energy. No hype. No dilution. Golden cross lining up. Once volume hits this float it could rip 100–200% in a blink. Most won’t catch it in time…. $CRDL $CVKD $NAOV $AMST $DRMA
0 · Reply
JOEtv
JOEtv Sep. 13 at 8:08 AM
$CRDL Never forget about me ;-)
0 · Reply
Myman2
Myman2 Sep. 12 at 1:51 PM
$CRDL Competitor knsa has tripled since i have been sitting in this Pretty annoying!
0 · Reply
ElieoG
ElieoG Sep. 12 at 12:44 AM
0 · Reply
Iceberg99
Iceberg99 Sep. 11 at 6:08 PM
0 · Reply
Covode13
Covode13 Sep. 11 at 4:38 PM
0 · Reply
BigWig8560
BigWig8560 Sep. 10 at 10:42 PM
$CRDL We all know Cardiol is going to need some money soon. While a full buyout from big pharma might not happen yet, I really think they could land a partnership or option-to-acquire deal instead—something that brings in big upfront cash without diluting shareholders. We’ve seen it recently with Novartis/PTC Therapeutics and Sanofi/Novavax, so it’s definitely possible here too. The addition of Timothy Cook to the board could be a big factor—he’s got the pharma connections and experience to help make a deal like this happen. These agreements aren’t easy to line up, but with the right people in place (which Cardiol now has), raising non-dilutive capital is absolutely on the table.
1 · Reply
Iceberg99
Iceberg99 Sep. 10 at 4:54 PM
$CRDL definitely bullish... It's not hard to see that this is a heart breakthrough. Amazing and I want some! 😆
0 · Reply
Phoenix54
Phoenix54 Sep. 10 at 1:58 PM
@DDavidson777 Hey GM.....What's your opinion on $CRDL? Does it have strong price increase, potential? Thanks
1 · Reply
G101SPM
G101SPM Sep. 9 at 2:55 PM
G101SPM 8/6/2025, 10:17:22 AM $CRDL $1.15 bid. DAC (8) $1.37. EXIT $6.00.
0 · Reply
G101SPM
G101SPM Sep. 9 at 2:54 PM
G101SPM 8/6/2025, 8:45:43 AM $CRDL $1.22 bid. DAC (8) $1.37. EXIT $6.00 (long term).
0 · Reply
NancyPelosi____insider
NancyPelosi____insider Sep. 9 at 2:43 PM
$CRDL gonna drop below a dollar (again) :) Esley go fuck yourself
0 · Reply
Youth_It
Youth_It Sep. 9 at 1:45 PM
$CRDL @ElieoG So why @Theo77 is posting that OLD NEWS ?? But let's be honest: does it really matter which conference presentation causes the share price to fall? Take that one for today !!
1 · Reply
Youth_It
Youth_It Sep. 9 at 11:12 AM
$CRDL Annual ¿ GROWTH ? Conference 🤣🤣🤣 0,90$ EOW
1 · Reply
mmtiddy
mmtiddy Sep. 8 at 5:03 AM
$CRDL I swear this company can announce it solved heart disease, cancer, world hunger, racism and it will still be down 20% because the threat of dilution
2 · Reply
ElieoG
ElieoG Sep. 5 at 10:14 PM
$CRDL another very high volume day. It wont stay 1.08-1.10 forever. Thumbs up (or heart sign) if you think it will shoot up soon .
1 · Reply
Covode13
Covode13 Sep. 5 at 2:48 PM
$CRDL 🤫🤫🤫🫣🫣
1 · Reply